caffeine has been researched along with naringin in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Culberson, JC; Kellogg, MS; Muller, GW; Roy, G; Schiffman, SS; Walters, DE; Warwick, ZS; Ziegler, J | 1 |
| Agrawal, P; Ballard, TL; Halaweish, FT; Stevermer, CL; Vukovich, MD | 1 |
| Maehashi, K; Matano, M; Nonaka, M; Udaka, S; Yamamoto, Y | 1 |
| Hernandez Salazar, LT; Laska, M; Rivas Bautista, RM | 1 |
| Huang, L; Malach, E; Naim, M; Peri, I; Seger, R; Shaul, ME; Spielman, AI | 1 |
| Durandin, N; Hopia, A; Laaksonen, T; Manninen, H; Vuorimaa-Laukkanen, E | 1 |
1 trial(s) available for caffeine and naringin
| Article | Year |
|---|---|
Naringin does not alter caffeine pharmacokinetics, energy expenditure, or cardiovascular haemodynamics in humans following caffeine consumption.
Topics: Adolescent; Adult; Algorithms; Anticholesteremic Agents; Blood Pressure; Caffeine; Central Nervous System Stimulants; Drug Interactions; Energy Metabolism; Female; Flavanones; Half-Life; Heart Rate; Hemodynamics; Humans; Male; Oxygen Consumption | 2006 |
6 other study(ies) available for caffeine and naringin
| Article | Year |
|---|---|
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Carboxylic acid replacement structure-activity relationships in suosan type sweeteners. A sweet taste antagonist. 1.
Topics: Aspartic Acid; beta-Alanine; Caffeine; Carboxylic Acids; Flavanones; Flavonoids; Humans; Phenylurea Compounds; Quinine; Structure-Activity Relationship; Sweetening Agents; Taste | 1992 |
Riboflavin-binding protein is a novel bitter inhibitor.
Topics: Acid Phosphatase; Adult; Caffeine; Dipeptides; Egg White; Egg Yolk; Female; Flavanones; Humans; Lactoglobulins; Male; Membrane Transport Proteins; Ovalbumin; Protein Binding; Quaternary Ammonium Compounds; Quinine; Receptors, G-Protein-Coupled; Serum Albumin, Bovine; Taste; Theobromine | 2008 |
Gustatory responsiveness to six bitter tastants in three species of nonhuman primates.
Topics: Animals; Atelinae; Behavior, Animal; Benzyl Alcohols; Caffeine; Choice Behavior; Flavanones; Food Preferences; Glucosides; Macaca nemestrina; Primates; Quaternary Ammonium Compounds; Quinine; Saimiri; Species Specificity; Sucrose; Taste; Taste Threshold | 2009 |
Membrane-permeable tastants amplify β2-adrenergic receptor signaling and delay receptor desensitization via intracellular inhibition of GRK2's kinase activity.
Topics: 1-Methyl-3-isobutylxanthine; Adrenergic beta-Agonists; Blotting, Western; Caffeine; Cell Membrane Permeability; Cyclic AMP; Enzyme Inhibitors; Flavanones; G-Protein-Coupled Receptor Kinase 2; HCT116 Cells; HEK293 Cells; HeLa Cells; Humans; Intracellular Space; Isoproterenol; Isoquinolines; Phosphorylation; Receptors, Adrenergic, beta-2; RNA Interference; Saccharin; Signal Transduction; Sulfonamides; Taste; Tryptophan | 2015 |
Taste compound - Nanocellulose interaction assessment by fluorescence indicator displacement assay.
Topics: Aspartame; Benzenesulfonates; Binding, Competitive; Caffeine; Cellulose; Congo Red; Diterpenes, Kaurane; Flavanones; Fluorescent Dyes; Glucosides; Nanostructures; Spectrophotometry, Ultraviolet; Taste | 2020 |